Net Margin - Fujian Cosunter Pharmaceutical Co Ltd (SZSE:300436) - Alpha Spread
F

Fujian Cosunter Pharmaceutical Co Ltd
SZSE:300436

Watchlist Manager
Fujian Cosunter Pharmaceutical Co Ltd
SZSE:300436
Watchlist
Price: 18.43 CNY -1.34% Market Closed
Market Cap: 2.9B CNY
Have any thoughts about
Fujian Cosunter Pharmaceutical Co Ltd?
Write Note

Net Margin
Fujian Cosunter Pharmaceutical Co Ltd

-66%
Current
-33%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-66%
=
Net Income
-299.9m
/
Revenue
454.5m

Net Margin Across Competitors

Country CN
Market Cap 2.9B CNY
Net Margin
-66%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 879.6B USD
Net Margin
19%
Country DK
Market Cap 4.1T DKK
Net Margin
35%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country US
Market Cap 400.6B USD
Net Margin
44%
Country US
Market Cap 299.1B USD
Net Margin
22%
Country CH
Market Cap 211.2B CHF
Net Margin
20%
Country UK
Market Cap 245.9B USD
Net Margin
13%
Country CH
Market Cap 192.9B CHF
Net Margin
33%
Country US
Market Cap 169B USD
Net Margin
-5%

Profitability Report

View the profitability report to see the full profitability analysis for Fujian Cosunter Pharmaceutical Co Ltd.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-66%
=
Net Income
-299.9m
/
Revenue
454.5m
What is the Net Margin of Fujian Cosunter Pharmaceutical Co Ltd?

Based on Fujian Cosunter Pharmaceutical Co Ltd's most recent financial statements, the company has Net Margin of -66%.